No Reconsideration of India's Watch List Status During IP Review, Says USTR
The Office of the U.S. Trade Representative will not reconsider its decision not to name India a Priority Foreign Country, the most severe classification of an intellectual property rights violator, as part of USTR’s Out-of-Cycle review on the country, the…
Sign up for a free preview to unlock the rest of this article
Timely, relevant coverage of court proceedings and agency rulings involving tariffs, classification, valuation, origin and antidumping and countervailing duties. Each day, Trade Law Daily subscribers receive a daily headline email, in-depth PDF edition and access to all relevant documents via our trade law source document library and website.
agency said on Oct. 14 (here). The pharmaceutical industry pushed USTR hard to slap that label on India in the agency’s Special 301 Watch List report in April. USTR asked the public for comments in recent days related to its review.